SBI Arbitrage Fund
SBI Mutual Fund · Arbitrage · Regular Idcw · AMFI 104458 · ISIN INF200K01131
NAV₹19.255619 Nov 2026
3Y return—a year
5Y return—a year
Expense ratio1.95%₹46,252 Cr
Growth Score—
Returns
| 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 7Y | 10Y | Since launch |
| Fund | — | — | — | — | — | — | — | — | — | — |
| Category middle | +0.57% | +1.39% | +2.91% | +5.19% | +5.86% | +6.54% | +6.07% | +5.49% | +5.70% | — |
Risk (36 months)
| Volatility | — |
| Sharpe | — |
| Sortino | — |
| Beta | — |
| Alpha | — |
| Deepest fall | — |
| 1-year periods with a loss | — |
| 5Y SIP XIRR | — |
Top holdings (31 Oct 2026)
| SBI Liquid Fund - DIRECT PLAN -Growth Opti | 7.29% |
| SBI Money Market Fund - Direct Plan - Grow | 7.10% |
| Reliance Industries Ltd. | 5.58% |
| HDFC Bank Ltd. | 4.07% |
| State Bank of India | 3.86% |
| Axis Bank Ltd. | 2.47% |
| ICICI Bank Ltd. | 2.37% |
| HDFC Bank Ltd. | 2.34% |
| Bharti Airtel Ltd. | 1.73% |
| Bajaj Finance Ltd. | 1.70% |
| Net Receivable / Payable | 1.66% |
| Adani Enterprises Ltd. | 1.62% |
Sectors
| Banks | 19.4% |
| Petroleum Products | 6.4% |
| Finance | 5.3% |
| Power | 4.3% |
| Pharmaceuticals & Biotechnology | 3.9% |
| Ferrous Metals | 3.6% |
| Telecom - Services | 3.3% |
| Aerospace & Defense | 2.4% |
Calculated by Growth Analyser from AMFI NAVs and the fund house's disclosed portfolio. Up to 1 year: total return; longer: CAGR. Research and education only; not investment advice. Mutual fund investments are subject to market risks; read all scheme-related documents carefully. Past performance does not indicate future returns.